Bidirectional correlation between COVID-19 and psychological disorders: a prospective cohort study of patients with COVID-19

[1]  T. Postolache,et al.  Onset of Mental Disorders Following Hospitalization for COVID-19: A 6-Month Follow-Up Study , 2023, COVID.

[2]  Yan Xie,et al.  Risks of mental health outcomes in people with covid-19: cohort study , 2022, BMJ.

[3]  Benjamin Bowe,et al.  Temporal trends of COVID-19 mortality and hospitalisation rates: an observational cohort study from the US Department of Veterans Affairs , 2021, BMJ Open.

[4]  E. K. Webb,et al.  Emotion Dysregulation Following Trauma: Shared Neurocircuitry of Traumatic Brain Injury and Trauma-Related Psychiatric Disorders , 2021, Biological Psychiatry.

[5]  I. Cobos,et al.  Dysregulation of brain and choroid plexus cell types in severe COVID-19 , 2021, Nature.

[6]  Ming Yang,et al.  A living systematic review of the psychological problems in people suffering from COVID-19 , 2021, Journal of Affective Disorders.

[7]  Benjamin Bowe,et al.  High-dimensional characterization of post-acute sequelae of COVID-19 , 2021, Nature.

[8]  E. Diamandis,et al.  COVID-19: from an acute to chronic disease? Potential long-term health consequences , 2020, Critical reviews in clinical laboratory sciences.

[9]  Mustafa Said Kıymaz,et al.  Understanding the Most Important Facilitators and Barriers for Online Education during COVID-19 through Online Photovoice Methodology , 2020 .

[10]  M. Gromiha,et al.  COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics , 2020, Infection.

[11]  F. Benedetti,et al.  Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors , 2020, Brain, Behavior, and Immunity.

[12]  A. Rodríguez-Lorenzana,et al.  Anxiety and depression in patients with confirmed and suspected COVID‐19 in Ecuador , 2020, Psychiatry and clinical neurosciences.

[13]  P. Mohammadkhani,et al.  Psychometric Properties of Persian Version of Structured Clinical Interview for DSM-5-Research Version (SCID-5-RV): A Diagnostic Accuracy Study , 2020, Iranian Journal of Psychiatry and Behavioral Sciences.

[14]  A. Shabani,et al.  Psychometric properties of Structured Clinical Interview for DSM‐5 Disorders‐Clinician Version (SCID‐5‐CV) , 2020, Brain and behavior.

[15]  Vasuki H. Dandu,et al.  Spectrum of neuropsychiatric manifestations in COVID-19 , 2020, Brain, Behavior, and Immunity.

[16]  C. Sudlow,et al.  Distinguishing between direct and indirect consequences of covid-19 , 2020, BMJ.

[17]  N. Manjunatha,et al.  Neuropsychiatric aspects of COVID-19 pandemic: A selective review , 2020, Asian Journal of Psychiatry.

[18]  M. Reger,et al.  Suicide Mortality and Coronavirus Disease 2019-A Perfect Storm? , 2020, JAMA psychiatry.

[19]  Y. Xiang,et al.  Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China , 2020, Psychological Medicine.

[20]  R. Martín-Santos,et al.  Clinical validity and intrarater and test–retest reliability of the Structured Clinical Interview for DSM‐5 – Clinician Version (SCID‐5‐CV) , 2019, Psychiatry and clinical neurosciences.

[21]  S. Shankman,et al.  Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM‐5 (SCID) , 2018, International journal of methods in psychiatric research.

[22]  H. Drexhage,et al.  Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders , 2013, Journal of Neuroimmune Pharmacology.

[23]  K. Rabiei,et al.  Psychometric Properties of the WHOQOL-BREF in an Iranian Adult Sample , 2010, Community Mental Health Journal.

[24]  M. Berlim,et al.  Reliability and validity of the WHOQOL BREF in a sample of Brazilian outpatients with major depression , 2005, Quality of Life Research.